High-throughput, multi-omics approach to determine and validate de novo global mechanisms of action for drugs and toxins
US10607721B2 · kind B2 · utility
0Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 22, 2016 |
| Grant date | Mar 31, 2020 |
| Priority date | — |
| Expiry date | Sep 4, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/20
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present disclosure provides for rapid identification of mechanism of action (MOA) for drugs and toxins, and does so in a rapid (30 days or less) fashion. The methods use a combination of high throughput bioinformatics and pathway analysis that examine a wide variety of biological parametics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.